According to Walgreens, which announced last year it was entering the clinical trials business, only about 5% of people in the U.S. participate in clinical trials and almost three-quarters of those participants are White.

A recent review of government-funded cancer research studies found that the participants were disproportionately white. A new state law attempts to fix that.